PortViewPortView
Treace Medical Concepts logo

Treace Medical Concepts (TMCI) Stock Analysis

NASDAQHealthcareMedical - Devices

$4.72+2.70%
1-year price historyRange $1.20 – $7.44
52-week range$4.72
$1.17$7.63

What Treace Medical Concepts does

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida.

Key metrics

Market cap
$306.49M
P/E (TTM)
-5.03
EPS (TTM)
$-0.94
Beta
1.40
Dividend yield
0.00%
Revenue / share
$3.16
50-day avg
$4.43
200-day avg
$2.89
52-week high
$7.63
52-week low
$1.17
CEO
John T. Treace

ETFs linked to TMCI

Broad-market and Healthcare sector ETFs an investor holding Treace Medical Concepts is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TMCI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TMCI in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Treace Medical Concepts?
Treace Medical Concepts trades under the ticker TMCI on NASDAQ.
Which exchange is TMCI listed on?
TMCI is listed on NASDAQ.
What sector does Treace Medical Concepts operate in?
Treace Medical Concepts is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze TMCI in a portfolio?
PortView shows TMCI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.